Czech National Bank grew its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 4.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 48,979 shares of the semiconductor company’s stock after purchasing an additional 1,981 shares during the period. Czech National Bank’s holdings in Synopsys were worth $23,006,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also made changes to their positions in SNPS. Alpine Bank Wealth Management increased its holdings in shares of Synopsys by 89.3% during the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock valued at $26,000 after purchasing an additional 25 shares in the last quarter. TFC Financial Management Inc. boosted its holdings in Synopsys by 1,250.0% during the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock worth $27,000 after buying an additional 50 shares in the last quarter. Millstone Evans Group LLC acquired a new stake in Synopsys during the third quarter valued at $27,000. SOA Wealth Advisors LLC. acquired a new stake in Synopsys during the third quarter valued at $28,000. Finally, McIlrath & Eck LLC purchased a new position in Synopsys in the third quarter valued at $29,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Stock Performance
SNPS opened at $410.13 on Thursday. The firm’s fifty day simple moving average is $447.48 and its two-hundred day simple moving average is $453.75. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The company has a market cap of $78.57 billion, a price-to-earnings ratio of 63.68, a PEG ratio of 3.39 and a beta of 1.15. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33.
Insider Transactions at Synopsys
In other Synopsys news, insider Janet Lee sold 250 shares of the business’s stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the sale, the insider directly owned 11,959 shares in the company, valued at approximately $6,338,270. The trade was a 2.05% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.56% of the company’s stock.
Analysts Set New Price Targets
A number of research analysts have weighed in on the stock. Rosenblatt Securities decreased their price objective on shares of Synopsys from $560.00 to $530.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Weiss Ratings restated a “hold (c)” rating on shares of Synopsys in a research note on Thursday, January 22nd. Morgan Stanley reaffirmed an “equal weight” rating and issued a $480.00 price target (down from $550.00) on shares of Synopsys in a report on Wednesday, February 25th. The Goldman Sachs Group set a $600.00 price target on Synopsys and gave the stock a “buy” rating in a research report on Wednesday, February 25th. Finally, Wall Street Zen raised Synopsys from a “sell” rating to a “hold” rating in a report on Saturday, December 13th. Eight research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $531.00.
Check Out Our Latest Research Report on Synopsys
Key Headlines Impacting Synopsys
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Elliott Investment Management has built a multibillion‑dollar stake and will engage management to improve revenue generation, profitability and AI‑focused growth — this raises the prospect of corporate actions (monetization push, capital‑allocation changes) that can unlock shareholder value. How Elliott’s Activist Stake and AI Push At Synopsys (SNPS) Has Changed Its Investment Story
- Positive Sentiment: Synopsys announced a collaboration with Arm to support the new Arm AGI data‑center CPU across EDA, IP and hardware‑assisted verification — strengthens Synopsys’ addressable market in AI/data‑center chip design and reinforces its positioning in full‑stack solutions. Synopsys Supports New Arm AGI CPU with Full-Stack Design Solutions
- Positive Sentiment: Analyst write‑ups highlight accelerating AI tool adoption — Zacks notes Design Automation revenues surging and AI features helping chip designers move faster, which supports revenue upside for Synopsys’ software and services. Can Rising AI Tool Adoption Lift Synopsys’ Design Automation Revenues?
- Positive Sentiment: Market reaction: coverage reports an earlier stock jump tied to the Elliott stake (momentum and investor attention can drive near‑term upside as strategies are debated). Nvidia-Backed Synopsys Stock Jumps as Elliott Takes Multibillion-Dollar Stake
- Neutral Sentiment: Synopsys has been a trending stock on Zacks/Yahoo — increased attention can widen trading ranges but doesn’t guarantee direction. Here is What to Know Beyond Why Synopsys, Inc. (SNPS) is a Trending Stock
- Neutral Sentiment: Multiple short‑interest data snippets in feeds show anomalous/zero values and appear unreliable — no clear signal from short data reported here. (Monitor official exchange filings for accurate short interest.)
- Neutral Sentiment: Technical/market‑pattern commentary exists but is descriptive rather than news‑driving; useful for traders but less so for fundamental investors. Unlocking the Hidden Patterns in Synopsys Stock Movements
- Negative Sentiment: Relative‑value commentary compares Synopsys unfavorably to NVIDIA for AI exposure and data‑center dominance — could temper investor enthusiasm and cause SNPS to lag peers if investors rotate to higher‑growth AI chip names. Synopsys vs. NVIDIA: Which Chip Ecosystem Stock Is the Better Bet?
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
